An idiopathic papillophlebitis associated macular edema case treated with intravitreal ranibizumab

Burak Simsek, Sevil Ari Yaylali, Nadim Bromand

Abstract


ABSTRACT

PURPOSE: To present an idiopathic papillophlebitis associated macular edema case treated with intravitreal ranibizumab

METHODS: Case Report

RESULTS: A 43-year-old woman presented with a complaint of acute loss of vision in the right eye. Visual acuity in the right eye at time of presentation was 0.2. Fundus examination revealed optic disc edema, venous engorgement and tortuosity and retinal hemorrhages.  Fluorescein angiography showed macular edema and a leakage from optic nerve head and retinal veins. The spectral domain optical coherence tomography (sd-OCT) revealed cystoid macular edema. She had no other pertinent medical history. Radiological imaging, systemic and hematologic evaluation was within normal limits except an elevated erythrocyte sedimentation rate. Intravitreal ranibizumab injection was performed. Improvement in visual acuity and partially regression of macular and optic disc edema were observed at first month examination. A recurrence of the macular edema was detected at the second month. At the second month examination after second ranibizumab injection visual acuity improved to 0.9, macular and optic disc edema completely regressed. There was no recurrence in macular edema during 9 months follow-up.

CONCLUSION: In spite of the possible recurrence, intravitreal ranibizumab can be an effective treatment modality in the management of the idiopathic papillophlebitis associated macular edema.

 

 

 

KEYWORDS: Idiopathic papillophlebitis; macular edema; ranibizumab


Full Text: PDF HTML

Refbacks

  • There are currently no refbacks.

Comments on this article

View all comments